Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies

7 Oct 2014

Abstract excerpt

PURPOSE: Ovarian cancer is a devastating disease and biomarkers for its early diagnosis are urgently required. Serum may be a valuable source of biomarkers that may be revealed by proteomic profiling. Herein, complementary serum protein profiling strategies were employed for discovery of biomarkers that could discriminate cases of malignant and benign ovarian cancer. EXPERIMENTAL DESIGN: Identically collected and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Advanced Proteomics Techniques and Applications
Share to Clusterin in disease pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25290619
DOI: 10.1002/prca.201400063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategiesPMID 25290619Read ↗

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerSemantic proximity Read ↗

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read ↗

Applications of Proteomics in Ovarian Cancer: Dawn of a New EraSemantic proximity Read ↗

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read ↗

Plasma protein and tumor tissue gene expression analyses in ovarian cancer reveals differentially co-regulated clusters between benign and malignant conditionsSemantic proximity Read ↗

Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers.Semantic proximity Read ↗

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read ↗

Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profilingSemantic proximity Read ↗

A novel proteomics-based plasma test for early detection of multiple cancers in the general populationSemantic proximity Read ↗

Multi-biomarker panel signature as the key to diagnosis of ovarian cancerSemantic proximity Read ↗

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancerSemantic proximity Read ↗

A data review and re-assessment of ovarian cancer serum proteomic profilingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.